Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 20,900 Shares

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 20,900 shares of the stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $14.94, for a total value of $312,246.00. Following the completion of the sale, the chief executive officer owned 109,218 shares in the company, valued at $1,631,716.92. This trade represents a 16.06% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Monday, April 6th, Virgilio Deloy Capobian Gibbon sold 770 shares of Afya stock. The shares were sold at an average price of $14.91, for a total transaction of $11,480.70.
• On Wednesday, April 1st, Virgilio Deloy Capobian Gibbon sold 19,500 shares of Afya stock. The shares were sold at an average price of $14.98, for a total transaction of $292,110.00.
• On Tuesday, March 31st, Virgilio Deloy Capobian Gibbon sold 2,320 shares of Afya stock. The shares were sold at an average price of $14.92, for a total transaction of $34,614.40.
• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The shares were sold at an average price of $15.21, for a total transaction of $12,168.00.
• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The shares were sold at an average price of $15.18, for a total transaction of $59,202.00.

Afya Trading Up 0.2%

Shares of AFYA opened at $14.99 on Tuesday. The firm’s 50 day simple moving average is $14.48 and its 200 day simple moving average is $14.70. The company has a market capitalization of $1.40 billion, a P/E ratio of 10.27, a P/E/G ratio of 0.67 and a beta of 0.48. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.20 and a quick ratio of 0.98. Afya Limited has a 1-year low of $13.00 and a 1-year high of $19.90.

Afya (NASDAQ:AFYA) last announced its earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The business had revenue of $147.08 million for the quarter, compared to the consensus estimate of $174.74 million. Sell-side analysts forecast that Afya Limited will post 1.52 earnings per share for the current fiscal year.

Afya Announces Dividend

The company also recently declared an annual dividend, which was paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th were given a dividend of $0.656 per share. The ex-dividend date was Wednesday, March 25th. This represents a yield of 433.0%. Afya’s dividend payout ratio (DPR) is presently 45.21%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of AFYA. Daiwa Securities Group Inc. purchased a new position in shares of Afya in the fourth quarter worth $43,000. Militia Capital Partners LP purchased a new position in shares of Afya in the second quarter worth $71,000. Quantbot Technologies LP purchased a new position in shares of Afya in the second quarter worth $117,000. State of Wyoming purchased a new position in shares of Afya in the second quarter worth $164,000. Finally, Van ECK Associates Corp increased its stake in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after buying an additional 1,377 shares during the period. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. restated a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research note on Friday, January 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. UBS Group reissued a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Finally, Bank of America downgraded shares of Afya from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $22.00 to $17.00 in a research note on Tuesday, February 24th. One equities research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $17.30.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.